Insiders Valerio Therapeutics

Equities

Market Closed - Euronext Paris Other stock markets 11:29:57 2024-05-08 EDT			5-day change	1st Jan Change
0.11 ^EUR	-0.90%		+1.85%	-33.33%

04-30	Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Onxeo SA has Changed its Name to Valerio Therapeutics	23-06-06	CI
Biophytis' Finance Chief Resigns; Onxeo Exec Named Successor	23-05-02	MT
Onxeo S.A. Appoints Khalil Barrage as New Board Member	22-06-16	CI
French Biotechnology Company Onxeo Names Chair as President/CEO	22-04-07	MT
Onxeo S.A. Announces the Appointment of Dr. Shefali Agarwal as President	22-04-07	CI
Onxeo S.A. Announces Executive Changes	22-04-07	CI
Onxeo Names Interim CEO	22-01-03	MT
Onxeo S.A. Appoints Julien Miara as Interim CEO	22-01-03	CI
Onxeo SA Appoints Bryan Giraudo as Independent Member of its Board of Directors Replacing Thomas Hofstaetter	21-11-23	CI
Onxeo SA Announces Board Appointments	21-10-14	CI
Onxeo S.A. Announces Appointment of Shefali Agarwal as the Chairwoman of the Board	21-07-29	CI
Onxeo S.A. Announces Board Changes	21-06-10	CI
Onxeo SA Announces Formation of Scientific Advisory Committee of Leading Independent Experts	21-05-31	CI
Onxeo SA Announces Board Changes	20-09-17	CI
Onxeo SA Announces Executive Changes	19-05-22	CI
Onxeo S.A. Establishes Scientific Advisory Board	17-11-28	CI
Onxeo SA Announces Executive Appointments	17-04-26	CI
Onxeo Announces Executive Appointments	17-03-01	CI
Onxeo Announces Establishment of U.S. Subsidiary; Appoints Philippe Maitre to Head U.S. Subsidiary	16-03-21	CI
Onxeo Announces Board Changes	16-01-25	CI

No results for this search